Science 37 Delivers Diverse Patient Enrollment in Respiratory Clinical Trial

In a study for a respiratory syncytial virus (RSV) vaccine, Science 37 was contracted to deliver end-to-end remote clinical trial management and workflow orchestration. The biotech sponsor needed improved recruitment, enrollment, retention, and diversity.

See how the Science 37 Direct-to-Patient Site met more than 85% black/hispanic enrollment by eliminating in-person monthly visits and enabling patients to participate from home.

Submit the form to watch the case study video.